PNT2002 - POINT Biopharma, Lantheus
rosopatamab-225Ac (CONV01-α) - Weill Cornell Medical College, Dominari Holdings
https://www.youtube.com/watch?v=cWwmT54CaHs
 
Jun 7, 2023
 
Prev Next